Broad Institute acquires license to all ChemAxon products and deploys across Chemical Biology Platform

news · 9 years ago

Compound registration, structure search and computed properties rolled out.

ChemAxon announced today that they have entered into an agreement with the Broad Institute of Harvard and MIT, which will license ChemAxon’s platform, discovery toolkits and desktop applications for institute-wide use. Broad will support their legacy small molecule registration system and other functionality across their Chemical Biology Platform with ChemAxon’s technology. In addition to ChemAxon’s discovery and desktop tools, the Broad Institute has already updated their core technology for archiving small molecules by deploying the JChem platform toolkit within their existing system.

"This adoption is a part of our strategy to provide our scientists in the Chemical Biology Platform with the most modern and capable tools to accelerate our research," said Michael Foley, Director of the Broad’s Chemical Biology Platform. "The extensive capabilities of the ChemAxon software support our ongoing efforts to build and apply state of the art facilities to support our work."

The evaluation and deployment is to be presented during ChemAxon’s User Group Meeting being held at Boston’s Omni Parker house, September 14-15.